STOK
#2122
Stoke Therapeutics, Inc. - Common Stock
24.4 1 USD
-0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-1.33%
Changement Mensuel
-16.92%
Evolution sur 6 mois
-28.85%
Changement Annuel
-19.12%
Clôture Précédente
24.7 4
Open
24.6 5
Low
24.2 5
High
24.6 7
Financials
- Market Capitalization 1.58 B
- Employee 170
- Founded 2014
- CEO N/A
- Website www.stoketherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00JPCBPG9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-264.5
ratio cours/chiffre d'affaires
10.19
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2080 |  OCUL Ocular Therapeutix, Inc. - Common Stock | 7.61 USD | +0.93% | +8.87% | -28.28% | -33.83% | 1.67 B USD | ||
| 2092 |  ABSI Absci Corporation - Common Stock | 9.58 USD | -5.71% | -14.62% | +19.30% | +157.53% | 1.64 B USD | ||
| 2132 |  INVA Innoviva, Inc. - Common Stock | 21.41 USD | +0.94% | +4.39% | +2.29% | +20.15% | 1.55 B USD | ||
| 2143 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 15.28 USD | -1.29% | +2.83% | +5.82% | -51.51% | 1.51 B USD |